LDB
CLB icon

Lee, Danner & Bass’s Core Laboratories CLB Stock Holding History

Lee, Danner & Bass’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$1.73K – 306
2024
Q4 		$1.73K Buy
+100
New +$1.93K ﹤0.01% 688

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lee, Danner & Bass's CLB Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 100 shares — an estimated $1.73K sold.

Lee, Danner & Bass first reported a position in CLB in Q4 2024 and held it in 1 quarter. The position peaked at $1.73K in Q4 2024. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Lee, Danner & Bass reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Lee, Danner & Bass sold 100 Core Laboratories shares in Q1 2025, an estimated $1.73K.
  • Lee, Danner & Bass first reported a position in Core Laboratories in Q4 2024 and held it in 1 quarter.
  • Lee, Danner & Bass's Core Laboratories position peaked at $1.73K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.